Timed delivery, or chronotherapy, of already established anti-cancer drugs has the potential to increase their efficacy and reduce toxicity, as the circadian clock controls processes that influence drug pharmacokinetics and pharmacodynamics [190]. This evidence concerns the gene CLOCK and cancer.